Salbutamol and orciprenaline-induced changes in myocardial function.
D000255:Adenosine Triphosphate / Q000032:analysis; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure; D001993:Bronchodilator Agents / Q000494:pharmacology*; D004285:Dogs; D005112:Extracorporeal Circulation; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D009921:Metaproterenol / Q000494:pharmacology*; D009206:Myocardium / Q000032:analysis; D010101:Oxygen Consumption / Q000187:drug effects; D010710:Phosphates / Q000032:analysis; D010725:Phosphocreatine / Q000032:analysis; D014628:Vagotomy
D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010710:Phosphates; D010725:Phosphocreatine; D009921:Metaproterenol; D000255:Adenosine Triphosphate; D007545:Isoproterenol